BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 33165922)

  • 1. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
    Monreal E; Maza S S; Gullón P; Natera-Villalba E; Chico-García JL; Beltrán-Corbellini Á; Martínez-Sanz J; García-Barragán N; Buisán J; Toledano R; Alonso-Canovas A; Pérez-Torre P; Matute-Lozano MC; López-Sendón JL; García-Ribas G; Corral Í; Fortún J; Montero-Errasquín B; Manzano L; Máiz-Carro L; Costa-Frossard L; Masjuan J;
    J Med Virol; 2021 Apr; 93(4):2243-2251. PubMed ID: 33165922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
    Monreal E; Sainz de la Maza S; Fernández-Velasco JI; Natera-Villalba E; Rita CG; Rodríguez-Jorge F; Beltrán-Corbellini Á; Iturrieta-Zuazo I; Rodríguez de Santiago E; Espiño M; de Andrés A; Fortún J; Barbero E; Vázquez M; Fernández Lucas M; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    J Clin Immunol; 2021 Feb; 41(2):315-323. PubMed ID: 33236261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment?
    Nevola R; Russo A; Scuotto S; Imbriani S; Aprea C; Abitabile M; Beccia D; Brin C; Carusone C; Cinone F; Cirigliano G; Colantuoni S; Cozzolino D; Cuomo G; Del Core M; Gjeloshi K; Marrone A; Medicamento G; Meo LA; Nappo F; Padula A; Pafundi PC; Ranieri R; Ricozzi C; Rinaldi L; Romano CP; Ruocco R; Ruosi C; Salvati A; Sasso FC; Sellitto A; Sommese P; Villani A; Coppola N; Adinolfi LE
    Respir Res; 2022 Dec; 23(1):327. PubMed ID: 36463178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
    Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
    Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
    Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune Responses to the Novel Coronavirus-2: Friend or Foe?
    Mahmoodpoor A; Nader ND
    Immunol Invest; 2021 Nov; 50(8):949-951. PubMed ID: 32689852
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
    Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
    J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.
    Dreher M; Kersten A; Bickenbach J; Balfanz P; Hartmann B; Cornelissen C; Daher A; Stöhr R; Kleines M; Lemmen SW; Brokmann JC; Müller T; Müller-Wieland D; Marx G; Marx N
    Dtsch Arztebl Int; 2020 Apr; 117(16):271-278. PubMed ID: 32519944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
    Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
    Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
    Allahyari A; Seddigh-Shamsi M; Mahmoudi M; Amel Jamehdar S; Amini M; Mozdourian M; Javidarabshahi Z; Eslami Hasan Abadi S; Amini S; Sedaghat A; Emadzadeh M; Moeini Nodeh M; Rahimi H; Bari A; Mozaheb Z; Kamandi M; Ataei Azimi S; Abrishami M; Akbarian A; Ataei P; Allahyari N; Hasanzadeh S; Saeedian N
    Int Immunopharmacol; 2021 Apr; 93():107239. PubMed ID: 33582019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.
    Fang XZ; Wang YX; Xu JQ; He YJ; Peng ZK; Shang Y
    Front Immunol; 2021; 12():651545. PubMed ID: 34149692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
    Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
    Front Immunol; 2022; 13():732197. PubMed ID: 35154090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of noninvasive ventilation failure and mortality in patients with acute respiratory distress syndrome: a systematic review and proportion meta-analysis.
    Wang J; Duan J; Zhou L
    BMC Pulm Med; 2024 Jan; 24(1):48. PubMed ID: 38254064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
    Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
    Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes.
    Bain W; Yang H; Shah FA; Suber T; Drohan C; Al-Yousif N; DeSensi RS; Bensen N; Schaefer C; Rosborough BR; Somasundaram A; Workman CJ; Lampenfeld C; Cillo AR; Cardello C; Shan F; Bruno TC; Vignali DAA; Ray P; Ray A; Zhang Y; Lee JS; Methé B; McVerry BJ; Morris A; Kitsios GD
    Ann Am Thorac Soc; 2021 Jul; 18(7):1202-1210. PubMed ID: 33544045
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support.
    Torregiani C; Veneroni C; Confalonieri P; Citton GM; Salton F; Jaber M; Confalonieri M; Dellaca' RL
    PLoS One; 2022; 17(3):e0265202. PubMed ID: 35312682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.